Organigram Holdings | OGI - Umsatzkosten

Aktienkurs
1.91
Täglich Wechseln
0.05 2.69%
Monatlich
3.24%
Jährlich
20.89%
Q2 Prognose
1.93




Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Cronos Group USD 28.74M 10.38M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
IQVIA Holdings USD 3.24B 518M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Moderna USD 452M 245M 2025-12
Organigram Holdings CAD 56.93M 20.53M 2025-12
Organon & Co USD 766M 21M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.56B 167.3M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12